Article Menu

Export Article

More by Authors Links

Article Data

  • Views 3109
  • Dowloads 131

Editorials

Open Access

Neuroendocrine neoplasms in gynaecological malignancies

  • Kentaro Kai1,*,
  • Kaei Nasu2

1Department of Obstetrics and Gynecology Oita University, Faculty of Medicine, 879-0855 Oita, Japan

2Division of Obstetrics and Gynecology, Support System for Community Medicine, Oita University Faculty of Medicine, 879-0855 Oita, Japan

DOI: 10.31083/j.ejgo.2021.02.2467 Vol.42,Issue 2,April 2021 pp.196-198

Submitted: 31 March 2021 Accepted: 02 April 2021

Published: 15 April 2021

*Corresponding Author(s): Kentaro Kai E-mail: kenta9sp@oita-u.ac.jp

PDF (154.3 kB) View Full-text

Cite and Share

Kentaro Kai,Kaei Nasu. Neuroendocrine neoplasms in gynaecological malignancies. European Journal of Gynaecological Oncology. 2021. 42(2);196-198.

URL:

https://www.ejgo.net/articles/10.31083/j.ejgo.2021.02.2467

References

[1] Kloppel G. Neuroendocrine neoplasms: dichotomy, origin and classifications. Visceral Medicine. 2017; 33: 324–330.

[2] Montuenga LM, Guembe L, Burrell MA, Bodegas ME, Calvo A, Sola JJ, et al. The diffuse endocrine system: from embryogenesis to carcinogenesis. Progress in Histochemistry and Cytochemistry. 2003; 38: 155–272.

[3] Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. Vol. 3. Lyon, France: IARC Press. 2010.

[4] Lioyd RV, Osamura RY, Kloppel G, Rosai J. WHO classification of tumours of endocrine organs. Vol. 10. Lyon, France: IARC Press. 2017.

[5] WHO Classification of Tumours Editorial Board. WHO classification of tumours. Digestive system tumours. Lyon, France: IARC Press. 2019.

[6] Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. Vol. 6. Lyon, France: IARC Press. 2014.

[7] WHO Classification of Tumours Editorial Board. WHO classification of tumors. Female genital tumours. Lyon, France: IARC Press. 2020.

[8] Wang Y, Hoang L, Ji JX, Huntsman DG. SWI/SNF complex mutations in gynecologic cancers: molecular mechanisms and models. Annual Review of Pathology. 2020; 15: 467–492.

[9] Kai K, Nasu K, Nishida H, Daa T, Shikama A, Shiozaki T, et al. Correlation of World Health Organization 2010 classification for gastroenteropancreatic neuroendocrine neoplasms with the prognosis of ovarian neuroendocrine neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study. Neuroendocrinology. 2020; 111: 320–329.

[10] Kuji S, Hirashima Y, Nakayama H, Nishio S, Otsuki T, Nagamitsu Y, et al. Diagnosis, clinicopathologic features, treatment, and prognosis of small cell carcinoma of the uterine cervix; Kansai Clinical Oncology Group/Intergroup study in Japan. Gynecologic Oncology. 2013; 129: 522–527.

[11] Matsumoto H, Shimokawa M, Nasu K, Shikama A, Shiozaki T, Futagami M, et al. Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan. Journal of Gynecologic Oncology. 2019; 30: e103.

[12] Network NCC. Cervical cancer. 2021. Available at: https://www. nccn.org/professionals/physician_gls/pdf/cervical.pdf (Accessed: 28 March 2021).

[13] Jamy O, Yaghmour G, Hare F, Martin MG. Population-based analysis of the clinical features of primary small cell carcinoma of the ovary. Anticancer Research. 2015; 35: 3091–3095.

[14] Schlechtweg K, Chen L, St Clair CM, Tergas AI, Khoury-Collado F, Hou JY, et al. Neuroendocrine carcinoma of the endometrium: Disease course, treatment, and outcomes. Gynecologic Oncology. 2019; 155: 254–261.

[15] Inamura K. Update on immunohistochemistry for the diagnosis of lung cancer. Cancers. 2018; 10: 72.

Submission Turnaround Time

Top